Phase II study demonstrating failure of both a five-drug continuous-therapy regimen and a two-drug pulse-therapy regimen in the treatment of metastatic neuroblastoma: Southwest Oncology Group Study 822.

Journal Article (Clinical Trial;Journal Article)

Twenty-six children greater than 1 year of age with previously untreated stage IV neuroblastoma were randomized to receive either a five-drug regimen (prednisone, cyclophosphamide, actinomycin D, vincristine, and daunorubicin) or a two-drug regimen (cyclophosphamide and vincristine). Complete response rates were 6% and 9% for the five-drug and the two-drug regimens respectively. Partial response rates were 13% and 27% for the five-drug and the two-drug regimens respectively. The mean duration of the seven responses was 9 months, and all 26 patients had died within 2 years. Neither regimen was effective for long-term disease control in these children with neuroblastoma.

Full Text

Duke Authors

Cited Authors

  • Doering, EJ; Nitschke, R; Haggard, ME; Land, VJ; Morgan, SK; Starling, K; Williams, T; George, S

Published Date

  • August 1, 1979

Published In

Volume / Issue

  • 63 / 8

Start / End Page

  • 1383 - 1384

PubMed ID

  • 476711

International Standard Serial Number (ISSN)

  • 0361-5960


  • eng

Conference Location

  • United States